CABALETTA BIO, INC. (CABA) Free cash flow 2019–2025
CABALETTA BIO, INC. (CABA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$132.3MFY2025 · since FY2019: -$16.7M → -$132.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$132.3M | -46.3% |
| FY2024 | -$90.4M | -66.7% |
| FY2023 | -$54.2M | -11.1% |
| FY2022 | -$48.8M | -38.4% |
| FY2021 | -$35.3M | -28.7% |
| FY2020 | -$27.4M | -63.7% |
| FY2019 | -$16.7M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More CABA financial trends
CABA RevenueCABA Net incomeCABA Net marginCABA Gross profitCABA Gross marginCABA Operating incomeCABA Operating marginCABA Operating cash flowCABA Capital expendituresCABA Return on equityCABA Stock buybacksCABA Dividends paidCABA Total assetsCABA Total liabilitiesCABA Shareholders’ equityCABA overview →